rs9435659

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_022089.4(ATP13A2):​c.3192C>T​(p.Ala1064Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.496 in 1,613,386 control chromosomes in the GnomAD database, including 204,781 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 14514 hom., cov: 32)
Exomes 𝑓: 0.50 ( 190267 hom. )

Consequence

ATP13A2
NM_022089.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: -0.360
Variant links:
Genes affected
ATP13A2 (HGNC:30213): (ATPase cation transporting 13A2) This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 1-16986848-G-A is Benign according to our data. Variant chr1-16986848-G-A is described in ClinVar as [Benign]. Clinvar id is 128473.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-16986848-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.36 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.525 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATP13A2NM_022089.4 linkuse as main transcriptc.3192C>T p.Ala1064Ala synonymous_variant 27/29 ENST00000326735.13 NP_071372.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATP13A2ENST00000326735.13 linkuse as main transcriptc.3192C>T p.Ala1064Ala synonymous_variant 27/291 NM_022089.4 ENSP00000327214.8 Q9NQ11-1

Frequencies

GnomAD3 genomes
AF:
0.412
AC:
62590
AN:
151924
Hom.:
14510
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.194
Gnomad AMI
AF:
0.474
Gnomad AMR
AF:
0.448
Gnomad ASJ
AF:
0.473
Gnomad EAS
AF:
0.282
Gnomad SAS
AF:
0.452
Gnomad FIN
AF:
0.475
Gnomad MID
AF:
0.415
Gnomad NFE
AF:
0.529
Gnomad OTH
AF:
0.429
GnomAD3 exomes
AF:
0.465
AC:
115999
AN:
249358
Hom.:
28075
AF XY:
0.471
AC XY:
63728
AN XY:
135168
show subpopulations
Gnomad AFR exome
AF:
0.188
Gnomad AMR exome
AF:
0.478
Gnomad ASJ exome
AF:
0.482
Gnomad EAS exome
AF:
0.289
Gnomad SAS exome
AF:
0.473
Gnomad FIN exome
AF:
0.481
Gnomad NFE exome
AF:
0.523
Gnomad OTH exome
AF:
0.470
GnomAD4 exome
AF:
0.505
AC:
737963
AN:
1461344
Hom.:
190267
Cov.:
74
AF XY:
0.505
AC XY:
367109
AN XY:
726996
show subpopulations
Gnomad4 AFR exome
AF:
0.178
Gnomad4 AMR exome
AF:
0.474
Gnomad4 ASJ exome
AF:
0.485
Gnomad4 EAS exome
AF:
0.307
Gnomad4 SAS exome
AF:
0.472
Gnomad4 FIN exome
AF:
0.487
Gnomad4 NFE exome
AF:
0.529
Gnomad4 OTH exome
AF:
0.474
GnomAD4 genome
AF:
0.412
AC:
62591
AN:
152042
Hom.:
14514
Cov.:
32
AF XY:
0.408
AC XY:
30310
AN XY:
74304
show subpopulations
Gnomad4 AFR
AF:
0.194
Gnomad4 AMR
AF:
0.448
Gnomad4 ASJ
AF:
0.473
Gnomad4 EAS
AF:
0.281
Gnomad4 SAS
AF:
0.453
Gnomad4 FIN
AF:
0.475
Gnomad4 NFE
AF:
0.529
Gnomad4 OTH
AF:
0.424
Alfa
AF:
0.480
Hom.:
8486
Bravo
AF:
0.400
Asia WGS
AF:
0.340
AC:
1182
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 15, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 73% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 68. Only high quality variants are reported. -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 15, 2013- -
not provided Benign:4
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 20, 2017- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 05, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicOct 22, 2015- -
Kufor-Rakeb syndrome Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Autosomal recessive spastic paraplegia type 78 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Kufor-Rakeb syndrome;C5567893:Autosomal recessive spastic paraplegia type 78 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 08, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.68
DANN
Benign
0.76
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs9435659; hg19: chr1-17313343; COSMIC: COSV58700662; COSMIC: COSV58700662; API